12:00 AM
 | 
Jun 30, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Peroxisome proliferation activated receptor γ coactivator 1α (PPARGC1A; PGC-1α)

Cancer

INDICATION: Prostate cancer

Patient sample, cell culture and mouse studies suggest promoting PPARGC1A expression could help treat metastatic prostate cancer. In prostate cancer patients, PPARGC1A levels were lower in primary tumor samples than...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >